SCHEMBL17151389

SCHEMBL17151389

Cc1cccc(NC2CCCOC2)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.48
▸ CACNA1B Q00975 2/20 0.48
▸ APBA1 Q02410 2/20 0.48
▸ MAPK1 P28482 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ HTT P42858 1/20 0.48
▸ IDH1 O75874 1/20 0.46
▸ PDE10A Q9Y233 1/20 0.46
▸ CTSK P43235 1/20 0.41
▸ HTR1A P08908 1/20 0.41
▸ DRD2 P14416 1/20 0.41
▸ DRD4 P21917 1/20 0.41
▸ CCNT1 O60563 2/20 0.41
▸ OPRM1 P35372 1/20 0.41
▸ MKNK1 Q9BUB5 1/20 0.40
▸ MKNK2 Q9HBH9 1/20 0.40
▸ GBA1 P04062 1/20 0.40
▸ MAPK8 P45983 1/20 0.39
▸ MAPK9 P45984 1/20 0.39
▸ MAPK10 P53779 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17303977 0.84 PDE10A (0.45) ALDH1A1CACNA1BAPBA1MAPK1KMT2A
SCHEMBL13915436 0.82 ALDH1A1 (0.60) ALDH1A1CACNA1BAPBA1MAPK1KMT2A
SCHEMBL17148513 0.82 IDH1 (0.49) MAPK1IDH1CTSKCCNT1MKNK1
SCHEMBL15830279 0.81 PDE10A (0.58) ALDH1A1CACNA1BAPBA1MAPK1KMT2A
SCHEMBL6468293 0.79 ALDH1A1 (0.51) ALDH1A1CACNA1BAPBA1MAPK1KMT2A
SCHEMBL30413715 0.76 MKNK1 (0.46) ALDH1A1MAPK1IDH1CCNT1MKNK1
SCHEMBL31019211 0.75 PDE10A (0.47) MAPK1HTTIDH1PDE10AMKNK1
SCHEMBL17151392 0.75 MKNK1 (0.55) MAPK1IDH1CTSKMKNK1MKNK2
SCHEMBL1699066 0.74 ALDH1A1 (0.54) ALDH1A1CACNA1BAPBA1MAPK1KMT2A
SCHEMBL1708933 0.74 ALDH1A1 (0.54) ALDH1A1CACNA1BAPBA1MAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9657009-B2 Heteroaryl substituted pyridyl compounds useful as kinase modulators BRISTOL-MYERS SQUIBB COMPANY (US) 2017-05-23 — — US disclosed
US-20150284382-A1 HETEROARYL SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS KINASE MODULATORS BRISTOL-MYERS SQUIBB COMPANY 2015-10-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150284382-A1 HETEROARYL SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS KINASE MODULATORS IRAK4, IRAK3, IRAK2 ALDH1A1 3586/4885CACNA1B 3575/4885APBA1 2225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback